BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 26239085)

  • 1. Copper-64-labeled anti-bcl-2 PNA-peptide conjugates selectively localize to bcl-2-positive tumors in mouse models of B-cell lymphoma.
    Jia F; Balaji BS; Gallazzi F; Lewis MR
    Nucl Med Biol; 2015 Nov; 42(11):809-15. PubMed ID: 26239085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular imaging of bcl-2 expression in small lymphocytic lymphoma using 111In-labeled PNA-peptide conjugates.
    Jia F; Figueroa SD; Gallazzi F; Balaji BS; Hannink M; Lever SZ; Hoffman TJ; Lewis MR
    J Nucl Med; 2008 Mar; 49(3):430-8. PubMed ID: 18287262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative biodistributions and dosimetry of [¹⁷⁷Lu]DOTA-anti-bcl-2-PNA-Tyr³-octreotate and [¹⁷⁷Lu]DOTA-Tyr³-octreotate in a mouse model of B-cell lymphoma/leukemia.
    Balkin ER; Liu D; Jia F; Ruthengael VC; Shaffer SM; Miller WH; Lewis MR
    Nucl Med Biol; 2014 Jan; 41(1):36-42. PubMed ID: 24267052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted antisense radiotherapy and dose fractionation using a (177)Lu-labeled anti-bcl-2 peptide nucleic acid-peptide conjugate.
    Liu D; Balkin ER; Jia F; Ruthengael VC; Smith CJ; Lewis MR
    Nucl Med Biol; 2015 Sep; 42(9):704-10. PubMed ID: 26081917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of radiometal-labeled and fluorescent cell-permeating peptide-PNA conjugates for targeting the bcl-2 proto-oncogene.
    Gallazzi F; Wang Y; Jia F; Shenoy N; Landon LA; Hannink M; Lever SZ; Lewis MR
    Bioconjug Chem; 2003; 14(6):1083-95. PubMed ID: 14624621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and Evaluation of (99m)Tc-Epidermal Growth Factor Receptor (EGFR)-Peptide Nucleic Acid for Visualization of EGFR Messenger RNA Expression in Malignant Tumors.
    Zhao X; Wang N; Ren X; Zhang J; Wang J; Han J; Jia L; Liu Y; Zhang Z
    J Nucl Med; 2014 Jun; 55(6):1008-16. PubMed ID: 24744447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroPET imaging of MCF-7 tumors in mice via unr mRNA-targeted peptide nucleic acids.
    Sun X; Fang H; Li X; Rossin R; Welch MJ; Taylor JS
    Bioconjug Chem; 2005; 16(2):294-305. PubMed ID: 15769082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroPET/CT imaging of patient-derived pancreatic cancer xenografts implanted subcutaneously or orthotopically in NOD-scid mice using (64)Cu-NOTA-panitumumab F(ab')2 fragments.
    Boyle AJ; Cao PJ; Hedley DW; Sidhu SS; Winnik MA; Reilly RM
    Nucl Med Biol; 2015 Feb; 42(2):71-7. PubMed ID: 25456837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro evaluation of targeted antisense 177Lu radiotherapy.
    Balkin ER; Jia F; Miller WH; Lewis MR
    Anticancer Res; 2011 Oct; 31(10):3143-9. PubMed ID: 21965720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of (64)Cu-labeled DOTA-D-Phe(1)-Tyr (3)-octreotide ((64)Cu-DOTA-TOC) for imaging somatostatin receptor-expressing tumors.
    Hanaoka H; Tominaga H; Yamada K; Paudyal P; Iida Y; Watanabe S; Paudyal B; Higuchi T; Oriuchi N; Endo K
    Ann Nucl Med; 2009 Aug; 23(6):559-67. PubMed ID: 19504168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "To serve and protect": enzyme inhibitors as radiopeptide escorts promote tumor targeting.
    Nock BA; Maina T; Krenning EP; de Jong M
    J Nucl Med; 2014 Jan; 55(1):121-7. PubMed ID: 24287321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET imaging of tumours with a 64Cu labeled macrobicyclic cage amine ligand tethered to Tyr3-octreotate.
    Paterson BM; Roselt P; Denoyer D; Cullinane C; Binns D; Noonan W; Jeffery CM; Price RI; White JM; Hicks RJ; Donnelly PS
    Dalton Trans; 2014 Jan; 43(3):1386-96. PubMed ID: 24202174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo evaluation and small-animal PET/CT of a prostate cancer mouse model using 64Cu bombesin analogs: side-by-side comparison of the CB-TE2A and DOTA chelation systems.
    Garrison JC; Rold TL; Sieckman GL; Figueroa SD; Volkert WA; Jurisson SS; Hoffman TJ
    J Nucl Med; 2007 Aug; 48(8):1327-37. PubMed ID: 17631556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. External imaging of CCND1, MYC, and KRAS oncogene mRNAs with tumor-targeted radionuclide-PNA-peptide chimeras.
    Tian X; Chakrabarti A; Amirkhanov NV; Aruva MR; Zhang K; Mathew B; Cardi C; Qin W; Sauter ER; Thakur ML; Wickstrom E
    Ann N Y Acad Sci; 2005 Nov; 1059():106-44. PubMed ID: 16382049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and evaluation of DOTA-conjugated Bombesin/RGD-antagonists for prostate cancer tumor imaging and therapy.
    Stott Reynolds TJ; Schehr R; Liu D; Xu J; Miao Y; Hoffman TJ; Rold TL; Lewis MR; Smith CJ
    Nucl Med Biol; 2015 Feb; 42(2):99-108. PubMed ID: 25459113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide.
    Wu Y; Zhang X; Xiong Z; Cheng Z; Fisher DR; Liu S; Gambhir SS; Chen X
    J Nucl Med; 2005 Oct; 46(10):1707-18. PubMed ID: 16204722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging human pancreatic cancer xenografts by targeting mutant KRAS2 mRNA with [(111)In]DOTA(n)-poly(diamidopropanoyl)(m)-KRAS2 PNA-D(Cys-Ser-Lys-Cys) nanoparticles.
    Amirkhanov NV; Zhang K; Aruva MR; Thakur ML; Wickstrom E
    Bioconjug Chem; 2010 Apr; 21(4):731-40. PubMed ID: 20232877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiometal-labeled peptide-PNA conjugates for targeting bcl-2 expression: preparation, characterization, and in vitro mRNA binding.
    Lewis MR; Jia F; Gallazzi F; Wang Y; Zhang J; Shenoy N; Lever SZ; Hannink M
    Bioconjug Chem; 2002; 13(6):1176-80. PubMed ID: 12440850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET imaging of CCND1 mRNA in human MCF7 estrogen receptor positive breast cancer xenografts with oncogene-specific [64Cu]chelator-peptide nucleic acid-IGF1 analog radiohybridization probes.
    Tian X; Aruva MR; Zhang K; Shanthly N; Cardi CA; Thakur ML; Wickstrom E
    J Nucl Med; 2007 Oct; 48(10):1699-707. PubMed ID: 17909257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.